AstraZeneca PLC (AZN)

201.53 -0.23 (-0.11%) USD  |  NYSE  |  Mar 04, 16:00
201.62 +0.09 (+0.04%) Pre-Market: 07:01
More

AstraZeneca Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for AZN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
GSK Plc Upgrade
Mereo BioPharma Group Plc --
Regeneron Pharmaceuticals, Inc. Upgrade
Biodexa Pharmaceuticals Plc --
Bicycle Therapeutics Plc Upgrade